Sumitomo Pharma Co., Ltd. (DNPUF)
OTCMKTS
· Delayed Price · Currency is USD
6.53
+0.73 (12.59%)
At close: May 2, 2025
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
| Pharmaceutical | 314.56B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Growth | -38.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
| North America | 159.04B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | -51.58% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan | 114.66B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | -9.08% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | 40.86B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Global | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Global Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Overseas | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Overseas Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|